世界の静脈内全身麻酔薬市場2023年:企業・地域・タイプ・用途別分析

◆英語タイトル:Global Intravenous General Anesthetics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書(GIR23SM7892)◆商品コード:GIR23SM7892
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2023年9月
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の静脈内全身麻酔薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の静脈内全身麻酔薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 静脈内全身麻酔薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

静脈内全身麻酔薬市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・鎮静剤、鎮痛剤、筋弛緩剤

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・AstraZeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B. Braun Melsungen、Liaoning Haisco、Pfizer、Teva Pharmaceutical Industries、Fresenius Kabi AG、SGPharma、Jiangsu Nhua Pharmaceutical Co., Ltd.、Xi'an Libang Pharmaceutical Co., Ltd.、Baxter international、Sichuan Guorui Pharmaceutical Co., Ltd.、Hikma

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、静脈内全身麻酔薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な静脈内全身麻酔薬メーカーの企業概要、2019年~2022年までの静脈内全身麻酔薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な静脈内全身麻酔薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別静脈内全身麻酔薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの静脈内全身麻酔薬のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での静脈内全身麻酔薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および静脈内全身麻酔薬の産業チェーンを掲載しています。
・第14、15章では、静脈内全身麻酔薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 静脈内全身麻酔薬の概要
– タイプ別分析(2018年vs2022年vs2029年):鎮静剤、鎮痛剤、筋弛緩剤
– 用途別分析(2018年vs2022年vs2029年):病院、診療所
– 世界の静脈内全身麻酔薬市場規模・予測
– 世界の静脈内全身麻酔薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– AstraZeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B. Braun Melsungen、Liaoning Haisco、Pfizer、Teva Pharmaceutical Industries、Fresenius Kabi AG、SGPharma、Jiangsu Nhua Pharmaceutical Co., Ltd.、Xi’an Libang Pharmaceutical Co., Ltd.、Baxter international、Sichuan Guorui Pharmaceutical Co., Ltd.、Hikma
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:鎮静剤、鎮痛剤、筋弛緩剤
・用途別分析2018年-2029年:病院、診療所
・静脈内全身麻酔薬の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・静脈内全身麻酔薬のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・静脈内全身麻酔薬のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・静脈内全身麻酔薬の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・静脈内全身麻酔薬の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Intravenous General Anesthetics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intravenous General Anesthetics Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sedative
1.3.3 Analgesics
1.3.4 Muscle Relaxants
1.4 Market Analysis by Application
1.4.1 Overview: Global Intravenous General Anesthetics Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Intravenous General Anesthetics Market Size & Forecast
1.5.1 Global Intravenous General Anesthetics Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intravenous General Anesthetics Sales Quantity (2018-2029)
1.5.3 Global Intravenous General Anesthetics Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Intravenous General Anesthetics Product and Services
2.1.4 AstraZeneca Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Fresenius-Kabi
2.2.1 Fresenius-Kabi Details
2.2.2 Fresenius-Kabi Major Business
2.2.3 Fresenius-Kabi Intravenous General Anesthetics Product and Services
2.2.4 Fresenius-Kabi Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Fresenius-Kabi Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Intravenous General Anesthetics Product and Services
2.3.4 AbbVie Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments/Updates
2.4 Baxter Healthcare
2.4.1 Baxter Healthcare Details
2.4.2 Baxter Healthcare Major Business
2.4.3 Baxter Healthcare Intravenous General Anesthetics Product and Services
2.4.4 Baxter Healthcare Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Baxter Healthcare Recent Developments/Updates
2.5 B. Braun Melsungen
2.5.1 B. Braun Melsungen Details
2.5.2 B. Braun Melsungen Major Business
2.5.3 B. Braun Melsungen Intravenous General Anesthetics Product and Services
2.5.4 B. Braun Melsungen Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 B. Braun Melsungen Recent Developments/Updates
2.6 Liaoning Haisco
2.6.1 Liaoning Haisco Details
2.6.2 Liaoning Haisco Major Business
2.6.3 Liaoning Haisco Intravenous General Anesthetics Product and Services
2.6.4 Liaoning Haisco Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Liaoning Haisco Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Intravenous General Anesthetics Product and Services
2.7.4 Pfizer Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Teva Pharmaceutical Industries
2.8.1 Teva Pharmaceutical Industries Details
2.8.2 Teva Pharmaceutical Industries Major Business
2.8.3 Teva Pharmaceutical Industries Intravenous General Anesthetics Product and Services
2.8.4 Teva Pharmaceutical Industries Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.9 Fresenius Kabi AG
2.9.1 Fresenius Kabi AG Details
2.9.2 Fresenius Kabi AG Major Business
2.9.3 Fresenius Kabi AG Intravenous General Anesthetics Product and Services
2.9.4 Fresenius Kabi AG Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fresenius Kabi AG Recent Developments/Updates
2.10 SGPharma
2.10.1 SGPharma Details
2.10.2 SGPharma Major Business
2.10.3 SGPharma Intravenous General Anesthetics Product and Services
2.10.4 SGPharma Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SGPharma Recent Developments/Updates
2.11 Jiangsu Nhua Pharmaceutical Co., Ltd.
2.11.1 Jiangsu Nhua Pharmaceutical Co., Ltd. Details
2.11.2 Jiangsu Nhua Pharmaceutical Co., Ltd. Major Business
2.11.3 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
2.11.4 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Xi’an Libang Pharmaceutical Co., Ltd.
2.12.1 Xi’an Libang Pharmaceutical Co., Ltd. Details
2.12.2 Xi’an Libang Pharmaceutical Co., Ltd. Major Business
2.12.3 Xi’an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
2.12.4 Xi’an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Xi’an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.13 Baxter international
2.13.1 Baxter international Details
2.13.2 Baxter international Major Business
2.13.3 Baxter international Intravenous General Anesthetics Product and Services
2.13.4 Baxter international Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Baxter international Recent Developments/Updates
2.14 Sichuan Guorui Pharmaceutical Co., Ltd.
2.14.1 Sichuan Guorui Pharmaceutical Co., Ltd. Details
2.14.2 Sichuan Guorui Pharmaceutical Co., Ltd. Major Business
2.14.3 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
2.14.4 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
2.15 Hikma
2.15.1 Hikma Details
2.15.2 Hikma Major Business
2.15.3 Hikma Intravenous General Anesthetics Product and Services
2.15.4 Hikma Intravenous General Anesthetics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hikma Recent Developments/Updates
3 Competitive Environment: Intravenous General Anesthetics by Manufacturer
3.1 Global Intravenous General Anesthetics Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intravenous General Anesthetics Revenue by Manufacturer (2018-2023)
3.3 Global Intravenous General Anesthetics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intravenous General Anesthetics by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intravenous General Anesthetics Manufacturer Market Share in 2022
3.4.2 Top 6 Intravenous General Anesthetics Manufacturer Market Share in 2022
3.5 Intravenous General Anesthetics Market: Overall Company Footprint Analysis
3.5.1 Intravenous General Anesthetics Market: Region Footprint
3.5.2 Intravenous General Anesthetics Market: Company Product Type Footprint
3.5.3 Intravenous General Anesthetics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intravenous General Anesthetics Market Size by Region
4.1.1 Global Intravenous General Anesthetics Sales Quantity by Region (2018-2029)
4.1.2 Global Intravenous General Anesthetics Consumption Value by Region (2018-2029)
4.1.3 Global Intravenous General Anesthetics Average Price by Region (2018-2029)
4.2 North America Intravenous General Anesthetics Consumption Value (2018-2029)
4.3 Europe Intravenous General Anesthetics Consumption Value (2018-2029)
4.4 Asia-Pacific Intravenous General Anesthetics Consumption Value (2018-2029)
4.5 South America Intravenous General Anesthetics Consumption Value (2018-2029)
4.6 Middle East and Africa Intravenous General Anesthetics Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
5.2 Global Intravenous General Anesthetics Consumption Value by Type (2018-2029)
5.3 Global Intravenous General Anesthetics Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
6.2 Global Intravenous General Anesthetics Consumption Value by Application (2018-2029)
6.3 Global Intravenous General Anesthetics Average Price by Application (2018-2029)
7 North America
7.1 North America Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
7.2 North America Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
7.3 North America Intravenous General Anesthetics Market Size by Country
7.3.1 North America Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
7.3.2 North America Intravenous General Anesthetics Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
8.2 Europe Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
8.3 Europe Intravenous General Anesthetics Market Size by Country
8.3.1 Europe Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
8.3.2 Europe Intravenous General Anesthetics Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intravenous General Anesthetics Market Size by Region
9.3.1 Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
10.2 South America Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
10.3 South America Intravenous General Anesthetics Market Size by Country
10.3.1 South America Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
10.3.2 South America Intravenous General Anesthetics Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intravenous General Anesthetics Market Size by Country
11.3.1 Middle East & Africa Intravenous General Anesthetics Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intravenous General Anesthetics Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intravenous General Anesthetics Market Drivers
12.2 Intravenous General Anesthetics Market Restraints
12.3 Intravenous General Anesthetics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intravenous General Anesthetics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravenous General Anesthetics
13.3 Intravenous General Anesthetics Production Process
13.4 Intravenous General Anesthetics Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravenous General Anesthetics Typical Distributors
14.3 Intravenous General Anesthetics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Intravenous General Anesthetics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intravenous General Anesthetics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Intravenous General Anesthetics Product and Services
Table 6. AstraZeneca Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 9. Fresenius-Kabi Major Business
Table 10. Fresenius-Kabi Intravenous General Anesthetics Product and Services
Table 11. Fresenius-Kabi Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Fresenius-Kabi Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Intravenous General Anesthetics Product and Services
Table 16. AbbVie Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AbbVie Recent Developments/Updates
Table 18. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 19. Baxter Healthcare Major Business
Table 20. Baxter Healthcare Intravenous General Anesthetics Product and Services
Table 21. Baxter Healthcare Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Baxter Healthcare Recent Developments/Updates
Table 23. B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Melsungen Major Business
Table 25. B. Braun Melsungen Intravenous General Anesthetics Product and Services
Table 26. B. Braun Melsungen Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. B. Braun Melsungen Recent Developments/Updates
Table 28. Liaoning Haisco Basic Information, Manufacturing Base and Competitors
Table 29. Liaoning Haisco Major Business
Table 30. Liaoning Haisco Intravenous General Anesthetics Product and Services
Table 31. Liaoning Haisco Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Liaoning Haisco Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Intravenous General Anesthetics Product and Services
Table 36. Pfizer Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical Industries Major Business
Table 40. Teva Pharmaceutical Industries Intravenous General Anesthetics Product and Services
Table 41. Teva Pharmaceutical Industries Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical Industries Recent Developments/Updates
Table 43. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 44. Fresenius Kabi AG Major Business
Table 45. Fresenius Kabi AG Intravenous General Anesthetics Product and Services
Table 46. Fresenius Kabi AG Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Fresenius Kabi AG Recent Developments/Updates
Table 48. SGPharma Basic Information, Manufacturing Base and Competitors
Table 49. SGPharma Major Business
Table 50. SGPharma Intravenous General Anesthetics Product and Services
Table 51. SGPharma Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SGPharma Recent Developments/Updates
Table 53. Jiangsu Nhua Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Jiangsu Nhua Pharmaceutical Co., Ltd. Major Business
Table 55. Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
Table 56. Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Xi'an Libang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Xi'an Libang Pharmaceutical Co., Ltd. Major Business
Table 60. Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
Table 61. Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Xi'an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Baxter international Basic Information, Manufacturing Base and Competitors
Table 64. Baxter international Major Business
Table 65. Baxter international Intravenous General Anesthetics Product and Services
Table 66. Baxter international Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Baxter international Recent Developments/Updates
Table 68. Sichuan Guorui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Sichuan Guorui Pharmaceutical Co., Ltd. Major Business
Table 70. Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product and Services
Table 71. Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 73. Hikma Basic Information, Manufacturing Base and Competitors
Table 74. Hikma Major Business
Table 75. Hikma Intravenous General Anesthetics Product and Services
Table 76. Hikma Intravenous General Anesthetics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hikma Recent Developments/Updates
Table 78. Global Intravenous General Anesthetics Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Intravenous General Anesthetics Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Intravenous General Anesthetics Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Intravenous General Anesthetics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Intravenous General Anesthetics Production Site of Key Manufacturer
Table 83. Intravenous General Anesthetics Market: Company Product Type Footprint
Table 84. Intravenous General Anesthetics Market: Company Product Application Footprint
Table 85. Intravenous General Anesthetics New Market Entrants and Barriers to Market Entry
Table 86. Intravenous General Anesthetics Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Intravenous General Anesthetics Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Intravenous General Anesthetics Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Intravenous General Anesthetics Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Intravenous General Anesthetics Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Intravenous General Anesthetics Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Intravenous General Anesthetics Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Intravenous General Anesthetics Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Intravenous General Anesthetics Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Intravenous General Anesthetics Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Intravenous General Anesthetics Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Intravenous General Anesthetics Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Intravenous General Anesthetics Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Intravenous General Anesthetics Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Intravenous General Anesthetics Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Intravenous General Anesthetics Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Intravenous General Anesthetics Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Intravenous General Anesthetics Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Intravenous General Anesthetics Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Intravenous General Anesthetics Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Intravenous General Anesthetics Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Intravenous General Anesthetics Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Intravenous General Anesthetics Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Intravenous General Anesthetics Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Intravenous General Anesthetics Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Intravenous General Anesthetics Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Intravenous General Anesthetics Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Intravenous General Anesthetics Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Intravenous General Anesthetics Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Intravenous General Anesthetics Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Intravenous General Anesthetics Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Intravenous General Anesthetics Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Intravenous General Anesthetics Raw Material
Table 146. Key Manufacturers of Intravenous General Anesthetics Raw Materials
Table 147. Intravenous General Anesthetics Typical Distributors
Table 148. Intravenous General Anesthetics Typical Customers
List of Figures
Figure 1. Intravenous General Anesthetics Picture
Figure 2. Global Intravenous General Anesthetics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intravenous General Anesthetics Consumption Value Market Share by Type in 2022
Figure 4. Sedative Examples
Figure 5. Analgesics Examples
Figure 6. Muscle Relaxants Examples
Figure 7. Global Intravenous General Anesthetics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Intravenous General Anesthetics Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Intravenous General Anesthetics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Intravenous General Anesthetics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Intravenous General Anesthetics Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Intravenous General Anesthetics Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Intravenous General Anesthetics Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Intravenous General Anesthetics Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Intravenous General Anesthetics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Intravenous General Anesthetics Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Intravenous General Anesthetics Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Intravenous General Anesthetics Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Intravenous General Anesthetics Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Intravenous General Anesthetics Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Intravenous General Anesthetics Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Intravenous General Anesthetics Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Intravenous General Anesthetics Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Intravenous General Anesthetics Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Intravenous General Anesthetics Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Intravenous General Anesthetics Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Intravenous General Anesthetics Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Intravenous General Anesthetics Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Intravenous General Anesthetics Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Intravenous General Anesthetics Consumption Value Market Share by Region (2018-2029)
Figure 53. China Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Intravenous General Anesthetics Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Intravenous General Anesthetics Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Intravenous General Anesthetics Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Intravenous General Anesthetics Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Intravenous General Anesthetics Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Intravenous General Anesthetics Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Intravenous General Anesthetics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Intravenous General Anesthetics Market Drivers
Figure 74. Intravenous General Anesthetics Market Restraints
Figure 75. Intravenous General Anesthetics Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Intravenous General Anesthetics in 2022
Figure 78. Manufacturing Process Analysis of Intravenous General Anesthetics
Figure 79. Intravenous General Anesthetics Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の静脈内全身麻酔薬市場2023年:企業・地域・タイプ・用途別分析(Global Intravenous General Anesthetics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆